top of page

最新消息

篩選條件:

Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

News & Updates

2025年5月30日

Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025

Read More
Lucence Demonstrates Combined ctDNA and ctRNA Liquid Biopsy Improves Diagnostic Yield at ASCO 2025
Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

News & Updates

2025年2月24日

Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India

Read More
Agilus Diagnostics and Lucence Announce Strategic Collaboration to Advance Cancer Testing Services in India
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

News & Updates

2025年1月10日

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

Read More
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

News & Updates

2025年1月2日

Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

Read More
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics
Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans

News & Updates

2024年10月28日

Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans

Read More
Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans
Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types

News & Updates

2024年10月2日

Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types

Read More
Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting

News & Updates

2024年7月4日

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting

Read More
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting
Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

News & Updates

2024年2月26日

Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

Read More
Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study
Interim Results from LIQUIK Prospective Study Released at WCLC 2023

News & Updates

2023年9月8日

Interim Results from LIQUIK Prospective Study Released at WCLC 2023

Read More
Interim Results from LIQUIK Prospective Study Released at WCLC 2023

1

/

5

bottom of page